About us
Our mission
Seabright develops solutions to power high-density and high-content clinical research in order to bring personalized insights on the genesis and evolution of diseases. These solutions include designing from the ground up new sample collection and stabilization technologies with a focus on patient centricity, convenience, and robustness, as well as how these are implemented in the laboratory and clinical studies.
We believe that elucidating complex, dynamic, and interconnected physiological events requires measuring the right signals at the right time. Whether blood, saliva, air, or other types of samples, Seabright focuses on clinical research applications that require longitudinal sampling of individuals and their environments with -omic or multiomic endpoints. Seabright has developed and selected technologies that are compatible with repeated use by the participants in any location they live, exercise, or work.
Seabright is a startup launched from technologies developed at the University of Washington in Seattle and founded by experts in patient-centric research in chronic diseases, immunology, and environmental exposures.
Co-founders
Dr. Sanitta Thongpang, President
Sanitta is leading the management of Seabright, where she brings experience in patient-centric platform development, execution of remote clinical studies, and multiomic analysis. She is building partnerships with leaders who leverage remote sampling including scientists in pharma, biotech, and academia as well as innovators in novel -omics analysis methods. She received BE and ME in Electrical and Computer Engineering from the University of Canterbury, New Zealand, a PhD in Biomedical Engineering from the University of Wisconsin-Madison, and a postdoctoral fellowship in rehabilitation engineering and neuroscience at the University of Washington. She was a faculty member in the department of Biomedical Engineering at Mahidol University specialized in neuroengineering and microfluidics. In 2020, she joined the Bioanalytical Chemistry for Medicine and the Environment (BCME) Lab to work on novel at-home diagnostics and longitudinal studies.
Prof. Ashleigh Theberge
Ashleigh is an Professor of Chemistry and Adjunct Professor of Urology at the University of Washington where she co-leads the Bioanalytical Chemistry for Medicine and the Environment (BCME) Lab . She received a BA in Chemistry from Williams College, a PhD in Chemistry from the University of Cambridge, UK, and a postdoctoral fellowship in Biomedical Engineering from the University of Wisconsin-Madison. Selected awards include a Kavli Microbiome Ideas Challenge Award grant (2017), an NIH Maximizing Investigators’ Research Award (MIRA, awarded 2018, renewed 2023), a Beckman Young Investigator Award (2018), a Packard Fellowship for Science and Engineering (2019), a Sloan Research Fellowship in Chemistry (2021), a Camille Dreyfus Teacher-Scholar Award (2022), and a Schmidt Science Polymath Award (2024).
Advisors
Dr. Erwin Berthier
Erwin is an Affiliate Professor of Chemistry and co-lead of the BCME Lab at the University of Washington and co-Founder of Tasso, Inc., a medical startup focused on facilitating access to blood-based diagnostics. He holds a Diplome d’Ingenieur from ENSTA in Paris, France, an MS in Electrical Engineering from the University of Canterbury in Christchurch, New Zealand, and a PhD in Biomedical Engineering from the University of Wisconsin-Madison followed by a postdoctoral fellowship in Medical Microbiology and Immunology. He is an author on over 70 publications in journals such as PNAS, Nature Communications, Blood, PLoS Pathogens, and Lab on a Chip.
